Skip to main content
Clinical Trials/NCT02231541
NCT02231541
Completed
Not Applicable

Effectiveness of Very Low Frequency Magnetic Fields in the Treatment of Fibromyalgia

University of Roma La Sapienza1 site in 1 country37 target enrollmentSeptember 2014
ConditionsFibromyalgia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fibromyalgia
Sponsor
University of Roma La Sapienza
Enrollment
37
Locations
1
Primary Endpoint
Change of Visual Analogue Scale (VAS) from baseline to 12 weeks
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of the study is to determine the effectiveness of treatment with very low frequency electromagnetic fields on the reduction of pain in patients with fibromylgia, disease presenting with widespread musculoskeletal pain usually associated with other symptoms such as stiffness, fatigue, sleep disturbances, depression, anxiety.

Registry
clinicaltrials.gov
Start Date
September 2014
End Date
March 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Female

Investigators

Sponsor
University of Roma La Sapienza
Responsible Party
Principal Investigator
Principal Investigator

Teresa Paolucci

medical director

University of Roma La Sapienza

Eligibility Criteria

Inclusion Criteria

  • Fibromyalgia diagnosed according to the criteria proposed by the American College of Rheumatology (ACR 2010)
  • Subjects aged between 18 and 60 years

Exclusion Criteria

  • Pregnant patients
  • Patients with pacemaker or other metal implants
  • Systemic infectious disorders
  • Neoplastic disorders
  • Severe heart disease

Outcomes

Primary Outcomes

Change of Visual Analogue Scale (VAS) from baseline to 12 weeks

Time Frame: baseline, 4 weeks, 12 weeks

It is a scale for the assessment of pain and it's based on a ten point scale, where 0 means no pain and 10 the greatest pain ever both at rest and during movements.

Secondary Outcomes

  • Change of Fibromylgia Impact Questionnaire (FIQ) from baseline to 12 weeks(baseline, 4 weeks, 12 weeks)
  • Change of Health Assessment Questionnaire (HAQ) from baseline to 12 weeks(baseline, 4 weeks, 12 weeks)
  • Change of Fibromylgia Assessment Status (FAS) from baseline to 12 weeks(baseline, 4 weeks, 12 weeks)

Study Sites (1)

Loading locations...

Similar Trials